Award
Delivery Order #SPE2DR26FMEP6
Delivery Order for Keytruda Medication to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$122,438.26
Ceiling
$122,438.26
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Apr 06, 2026
Identifier
SPE2DR26FMEP6
NAICS
424210
This contract represents a delivery order under an existing indefinite delivery vehicle awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and healthcare solutions. The order procures a specific cancer treatment medication, Keytruda (100 mg/4 ml vial), essential for supporting government healthcare programs. This delivery highlights the contract's role in maintaining a steady and reliable supply of critical pharmaceutical products to government health facilities, impacting patient treatment and care. The scope involves the timely delivery of this medication as part of ongoing pharmaceutical procurement efforts under the parent contract, which spans over a decade. This delivery order, awarded competitively under the umbrella of the broader agreement, covers a short performance period, ensuring prompt fulfillment and continuity in medication availability.
Description
4571189448!KEYTRUDA 100 MG/4 ML VIAL 4ML